118 related articles for article (PubMed ID: 38902550)
41. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study.
Bulakci M; Ercan CC; Karapinar E; Aksakal MZT; Aliyev S; Bicen F; Sahin AY; Salmaslioglu A
Pediatr Radiol; 2023 Jul; 53(8):1629-1639. PubMed ID: 36881143
[TBL] [Abstract][Full Text] [Related]
42. Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.
Kramer H; Pickhardt PJ; Kliewer MA; Hernando D; Chen GH; Zagzebski JA; Reeder SB
AJR Am J Roentgenol; 2017 Jan; 208(1):92-100. PubMed ID: 27726414
[TBL] [Abstract][Full Text] [Related]
43. Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard.
Jeon SK; Joo I; Kim SY; Jang JK; Park J; Park HS; Lee ES; Lee JM
Ultrasonography; 2021 Jan; 40(1):136-146. PubMed ID: 32654442
[TBL] [Abstract][Full Text] [Related]
44. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.
Jia S; Zhao Y; Liu J; Guo X; Chen M; Zhou S; Zhou J
Front Pediatr; 2021; 9():784221. PubMed ID: 35087774
[No Abstract] [Full Text] [Related]
45. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
Yoo J; Joo I; Jeon SK; Park J; Yoon SH
Eur Radiol; 2024 Feb; ():. PubMed ID: 38393403
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
48. Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction.
Zeng Q; Song Z; Zhao Y; Wu J; Wang L; Ye H; Wang Y; Wu T; Yuan S; Yuan H
Hepatol Res; 2020 May; 50(5):578-587. PubMed ID: 31883216
[TBL] [Abstract][Full Text] [Related]
49. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
50. Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.
Bende F; Sporea I; Șirli R; Bâldea V; Lazăr A; Lupușoru R; Fofiu R; Popescu A
Med Ultrason; 2021 Feb; 23(1):7-14. PubMed ID: 33220028
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases.
Ni XX; Lian M; Wu HM; Li XY; Sheng L; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Hua J
World J Gastroenterol; 2021 Jan; 27(1):80-91. PubMed ID: 33505152
[TBL] [Abstract][Full Text] [Related]
52. Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children.
Jia S; Zhou J; Zhang Q; Zhou S; Wang Z; Ye X; Wu J
Clinics (Sao Paulo); 2024; 79():100387. PubMed ID: 38805982
[TBL] [Abstract][Full Text] [Related]
53. Quantitative determination of liver triglyceride levels with 3T ¹H-MR spectroscopy in mice with moderately elevated liver fat content.
Runge JH; Bakker PJ; Gaemers IC; Verheij J; Hakvoort TB; Ottenhoff R; Stoker J; Nederveen AJ
Acad Radiol; 2014 Nov; 21(11):1446-54. PubMed ID: 25300722
[TBL] [Abstract][Full Text] [Related]
54. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
[TBL] [Abstract][Full Text] [Related]
55. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
Beyer C; Hutton C; Andersson A; Imajo K; Nakajima A; Kiker D; Banerjee R; Dennis A
PLoS One; 2021; 16(4):e0249491. PubMed ID: 33793651
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of Controlled Attenuation Parameter for Identification and Grading of Nonalcoholic Fatty Liver Disease in Adolescents with Obesity.
Anand A; Shalimar ; Jana M; Kandasamy D; Kumar B; Singh G; Jain V
Indian J Pediatr; 2022 Jan; 89(1):52-58. PubMed ID: 34324132
[TBL] [Abstract][Full Text] [Related]
58. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.
Dioguardi Burgio M; Castera L; Oufighou M; Rautou PE; Paradis V; Bedossa P; Sartoris R; Ronot M; Bodard S; Garteiser P; Van Beers B; Valla D; Vilgrain V; Correas JM;
Clin Gastroenterol Hepatol; 2024 May; 22(5):1005-1013.e27. PubMed ID: 38072287
[TBL] [Abstract][Full Text] [Related]
59. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
[TBL] [Abstract][Full Text] [Related]
60. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
Jung J; Han A; Madamba E; Bettencourt R; Loomba RR; Boehringer AS; Andre MP; Erdman JW; O'Brien WD; Fowler KJ; Sirlin CB; Loomba R
Radiology; 2022 Jul; 304(1):75-82. PubMed ID: 35348378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
